The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

In addition, it can allow the buildup of a small molecule known as methylmalonic acid (MMA). In healthy tissues, vitamin B12 helps break down MMA. In B12 deficient patients, MMA is increased and can ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine ...

BRD-810 restores the normal apoptotic process by inhibiting a protein called MCL1, which normally protects cells from ...

In a dramatic turn of events that makes for some great storytelling, Cidara's novel drug-Fc conjugate, once locked up in a ...

Researchers found a molecule, sulfuretin, can promote myelin repair, slowing disease progression in MS and some cancers.

November 8, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for ...

A year out from Leqembi’s approval for Alzheimer’s disease (AD), ongoing research coupled with artificial intelligence is ...

On the heels of its most advanced medicine flunking a key study, the drugmaker is looking at the different paths it could ...

Preliminary results from Phase 1 ACESOT-1051 trial of WEE1 inhibitor, APR-1051, demonstrate the product to be well-tolerated with no unexpected ...

Interim analysis for Study 1 of Essential3 Phase 3 program for ulixacaltamide in essential tremor (ET) confirmed for Q1 2025; NDA filing ...